Relevance Ventures Leads Series B Funding for Aqua Medical's PIMA Procedure

Relevance Ventures has led a Series B financing round for Aqua Medical, Inc., providing crucial support for the company's ongoing U.S. RESTORE-1 pilot study and operational preparations to initiate a planned U.S. pivotal trial for its investigational Proximal Intestinal Mucosal Ablation (PIMA) procedure for Type 2 diabetes.